David Gottlieb
Overview
Explore the profile of David Gottlieb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Westall G, Gottlieb D, Hughes P, Marinelli T, Rawlinson W, Ritchie D, et al.
Intern Med J
. 2024 Dec;
55(1):12-19.
PMID: 39620697
Cytomegalovirus (CMV) infections continue to be associated with significant morbidity and mortality following solid organ transplantation and haemopoietic stem cell transplantation. Advances in understanding the biology of CMV in the...
2.
Stern L, McGuire H, Avdic S, Blyth E, Gottlieb D, Patrick E, et al.
Clin Transl Immunology
. 2023 Nov;
12(12):e16815.
PMID: 38034080
Objectives: Human cytomegalovirus (HCMV) reactivation is the leading viral complication after allogeneic haematopoietic stem cell transplantation (allo-HSCT). Understanding of circulating cytokine/chemokine patterns which accompany HCMV reactivation and correlate with HCMV...
3.
Louie R, Cai C, Samir J, Singh M, Deveson I, Ferguson J, et al.
Nat Commun
. 2023 Nov;
14(1):7767.
PMID: 38012187
Chimeric antigen receptor (CAR) T cell therapy is effective in treating B cell malignancies, but factors influencing the persistence of functional CAR T cells, such as product composition, patients' lymphodepletion,...
4.
McErlean G, Tapp C, Brice L, Gilroy N, Kabir M, Greenwood M, et al.
BMC Psychol
. 2023 Aug;
11(1):235.
PMID: 37587508
Aims: Given the increasing number of Hematopoietic Stem Cell Transplantations (HSCT) performed world-wide, the increasing likelihood of survival following HSCT, and the profound physical, psychosocial, and emotional impact of HSCT...
5.
Moore J, Hamad N, Gottlieb D, Bajel A, Ritchie D, Yeung D, et al.
Blood Adv
. 2023 Jul;
7(18):5554-5565.
PMID: 37467011
Haploidentical hematopoietic stem cell transplant (haplo-HSCT) using posttransplant cyclophosphamide (PTCy) is appropriate for those who lack matched donors. Most studies using PTCy have been retrospective making conclusions difficult. ANZHIT-1 was...
6.
McErlean G, Tapp C, Brice L, Pradhan A, Gilroy N, Kabir M, et al.
Clin Nurs Res
. 2023 Jun;
32(8):1134-1144.
PMID: 37329124
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an intensive but effective treatment for malignant and non-malignant diseases. However, long-term survival often comes at a cost, with survivors experiencing chronic morbidity...
7.
Ai H, Chao N, Rizzieri D, Huang X, Spitzer T, Wang J, et al.
Heliyon
. 2023 Apr;
9(4):e14924.
PMID: 37089296
Recent studies have shown that microtransplant (MST) could improve outcome of patients with elderly acute myeloid leukemia (EAML). To further standardize the MST therapy and improve outcomes in EAML patients,...
8.
Blennerhassett R, Othman J, Biscoe A, Kliman D, Mills G, Blyth E, et al.
Intern Med J
. 2023 Mar;
53(11):1979-1986.
PMID: 36878730
Background: Corticosteroids (CSs) have previously been incorporated into graft versus host disease (GVHD) prophylaxis regimens for bone marrow (BM) and haemopoietic stem cell transplant (HSCT). Aims: To assess the impact...
9.
Stern L, McGuire H, Avdic S, Fazekas de St. Groth B, Gottlieb D, Abendroth A, et al.
Nat Commun
. 2022 May;
13(1):2603.
PMID: 35546552
Human cytomegalovirus reactivation is a major opportunistic infection after allogeneic haematopoietic stem cell transplantation and has a complex relationship with post-transplant immune reconstitution. Here, we use mass cytometry to define...
10.
Kliman D, Tran S, Kennedy G, Curley C, McLean A, Gottlieb D, et al.
Bone Marrow Transplant
. 2022 Apr;
57(6):982-989.
PMID: 35440804
Unrelated donors (UDs) are the commonest source for allogeneic transplantation (alloSCT), with higher non-relapse mortality (NRM) than siblings. We analyzed data from the Australasian Bone Marrow Transplant Recipient Registry from...